Edition:
United Kingdom

Lonza Group AG (LONN.S)

LONN.S on Virt-X Level 1

312.30CHF
4:30pm GMT
Change (% chg)

CHF5.90 (+1.93%)
Prev Close
CHF306.40
Open
CHF307.80
Day's High
CHF313.80
Day's Low
CHF305.50
Volume
144,684
Avg. Vol
293,347
52-wk High
CHF342.00
52-wk Low
CHF218.00

Chart for

About

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a... (more)

Overall

Beta: 0.99
Market Cap(Mil.): CHF19,317.19
Shares Outstanding(Mil.): 74.47
Dividend: 2.55
Yield (%): 0.98

Financials

  LONN.S Industry Sector
P/E (TTM): 46.00 69.71 34.39
EPS (TTM): 5.64 -- --
ROI: 5.24 9.01 14.96
ROE: 9.24 10.15 16.52

BRIEF-Lonza To Establish Strategic Biomanufacturing Base In China

* LONZA TO ESTABLISH STRATEGIC BIOMANUFACTURING BASE IN CHINA USING GE HEALTHCARE SOLUTION

10 Dec 2018

BRIEF-Lonza Granted U.S. Patent for L-Carnitine in Animal Nutrition

* LONZA HAS BEEN GRANTED U.S. PATENT 10,016,382 FOR L-CARNITINE USE IN PET FOOD FOR ITS BENEFICIAL IMPACT ON PERFORMANCE AND RECOVERY IN ACTIVE DOGS Source text for Eikon: [https://bit.ly/2QyBNTQ] Further company coverage: (Reporting by Berlin Speed Desk)

05 Dec 2018

BRIEF-Lonza Says Water Care France Now Included In Deal With Platinum Equity

* WATER CARE FRANCE TO BE INCLUDED IN THE TRANSITION TO PLATINUM EQUITY

14 Nov 2018

BRIEF-Lonza Group Signs Agreement To Divest Water Care Business To Platinum Equity

* LONZA FURTHER STRENGTHENS FOCUS ON ITS HEALTHCARE CONTINUUM STRATEGY BY SIGNING AGREEMENT TO DIVEST WATER CARE BUSINESS TO PLATINUM EQUITY

01 Nov 2018

BRIEF-Lonza Acquires A Controlling Stake In Octane Biotech

* LONZA ACQUIRES A CONTROLLING STAKE IN OCTANE BIOTECH TO FURTHER DEVELOP COCOONTM AUTOLOGOUS TECHNOLOGY

29 Oct 2018

BRIEF-Lonza - Production In Nansha To Close For Maintenance

* WILL SHUT DOWN ITS PRODUCTION OF NIACINAMIDE (VITAMIN B3) IN NANSHA (CN) IN DECEMBER 2018 TO PERFORM ROUTINE MAINTENANCE AND PROCESS OPTIMIZATION Further company coverage: (Berlin Speed Desk)

19 Oct 2018

BRIEF-Lonza Group Affirms 2022 Guidance at Capital Markets Day

* CAPITAL MARKETS DAY 2018 OUTLINES SUSTAINABLE GROWTH PLANS THROUGH FOCUS AND INVESTMENT

25 Sep 2018

BRIEF-Lonza Group AG Expands Its Distribution Relationship With Azelis Americas

* SAYS LONZA CONSUMER PRODUCT INGREDIENTS EXPANDS ITS DISTRIBUTION RELATIONSHIP WITH AZELIS AMERICAS

16 Jul 2018

Earnings vs. Estimates